GLP-1 drugs like Ozempic and Mounjaro show no increased thyroid cancer risk in human data, despite lawsuits over stomach ...

A 2026 review summarised the safety profile of GLP-1 receptor agonists and related incretin therapies used for type 2 diabetes and obesity. The most common problems are gastrointestinal and often ...

GLP-1 medications have transformed obesity treatment and renewed attention on the science behind medical weight loss. But health experts say one important truth remains: medication alone isn’t ...

Long-Term Effects of Ozempic This article was reviewed by Lynn Marie Morski, MD, JD. You may have heard about — or maybe even ...

As more continues to be understood about the health benefits associated with GLP-1 drugs, a growing body of science is aiming to answer whether the popular weight-loss medication can help with one of ...